These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9520157)

  • 1. Cell membrane perturbations and vincristine transport in sensitive and resistant HL-60 cell lines.
    Zichner S; Zimmer G; Woodcock BG
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):99-102. PubMed ID: 9520157
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of vincristine cytotoxicity by dexverapamil in sensitive and resistant HL-60 cell lines as a function of extracellular protein binding.
    Stratmann G; Harder S; Hölzer D; Hofmann WK; Ottmann OG; Woodcock BG
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):103-6. PubMed ID: 9520158
    [No Abstract]   [Full Text] [Related]  

  • 3. Transmembranous transport of drugs: implications for kinetics and drug action.
    Stratmann G; Jarosch A; Sulzbacher A; Schüler R; Kümel G; Woodcock BG
    Int J Clin Pharmacol Ther; 1997 Apr; 35(4):151-4. PubMed ID: 9112135
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of phorbol myristate acetate (PMA) on P-glycoprotein mediated vincristine resistance of L1210 cells.
    Barancík M; Stefanková Z; Breier A
    Gen Physiol Biophys; 1995 Apr; 14(2):171-5. PubMed ID: 8846884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M; Morris MB; Roufogalis BD
    Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
    Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
    Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain and loss of hypersensitivity to resistance modifiers in multidrug resistant Chinese hamster ovary cells.
    Warr JR; Quinn D; Elend M; Fenton JA
    Cancer Lett; 1995 Nov; 98(1):115-20. PubMed ID: 8529199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma membrane fluidity and R-verapamil action in CHO cells.
    Schuldes H; Dolderer J; Knobloch J; Bade S; Bickeböller R; Woodcock BG; Jonas D; Zimmer G
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):71-3. PubMed ID: 9520147
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT; Sharma R; Grady JJ; Awasthi S
    Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of Selol in multidrug-resistant and sensitive human leukemia cells.
    Suchocki P; Misiewicz I; Skupinska K; Waclawek K; Fijalek Z; Kasprzycka-Guttman T
    Oncol Rep; 2007 Oct; 18(4):893-9. PubMed ID: 17786352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
    Wang J; Xia Y; Wang H; Hou Z
    Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of miltefosine on membrane permeability and accumulation of [99mTc]-hexakis-2-methoxyisobutyl isonitrile, 2-[18F]fluoro-2-deoxy-D-glucose, daunorubucin and rhodamine123 in multidrug-resistant and sensitive cells.
    Márián T; Balkay L; Trón L; Krasznai ZT; Szabó-Péli J; Krasznai Z
    Eur J Pharm Sci; 2005 Apr; 24(5):495-501. PubMed ID: 15784339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.
    Delannoy S; Urbatsch IL; Tombline G; Senior AE; Vogel PD
    Biochemistry; 2005 Oct; 44(42):14010-9. PubMed ID: 16229490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.